Sir Martin Evans Celixir , Nobel Laureate, and Ajan Reginald, former Global Head of Emerging Technologies at Roche, were two of the famous personalities which founded Cell Therapy Ltd (CTL) in 2009. Eventually, CTL was rebranded as Celixir in the year 2016. This is where their professional team of world-class scientists and biotechnology leadership are indulged in innovating breakthrough medicines to change the level of medical care for patients around.
Their team is solely focused on bringing breakthrough cell and gene therapies in order to treat all the incurable or ill- treated diseases including heart failure and cancer. The company has further brought the following set of values to their core working ethics and beliefs.